• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Global Equity

Chinese Statistics Diverge From Covid Reality as Traders Fall Sick

Many businesses in China report difficulties due to staffing shortages, but the official tallies of infections and deaths don't reflect that situation.
By ALEX FREW MCMILLAN
Dec 19, 2022 | 08:10 AM EST
Stocks quotes in this article: BABA, RNECY

Anecdotal evidence indicates Covid-19 is sweeping through China, which here on Monday reported its first official deaths from the disease in two weeks. But the official statistics are diverging from reality, making it hard to get an accurate picture as to the extent of the effects of the disease.

Beijing is reporting two Covid deaths, according to the official tally from the Chinese Center for Disease Control and Prevention. Those are the first deaths reported by the authorities since Dec. 3.

However, local reports note that the designated Covid-19 crematoriums have lines of hearses waiting outside them. As we saw early in the original Wuhan Covid outbreak, it is likely that local authorities do not want to record deaths in their district. They may pressure relatives to accept causes such as "pneumonia" on a death certificate and to cremate the body quickly before any autopsy is possible.

Reuters on Saturday afternoon counted 30 hearses stopped outside the driveway to the Dongjiao funeral home, a Covid crematorium in Beijing. There were also 20 body bags on the floor of the neighboring funeral home with no official Covid deaths reported that day and none since Nov. 23. Workers in hazmat suits handled all cases.

China today reported 1,995 confirmed new cases of Covid on Sunday. However, it has stopped counting asymptomatic Covid cases, where people test positive for the disease but don't show its effects.

Because testing for Covid was required daily for many activities but has stopped in most locations across China, the official numbers are no longer comparable with the figures from before Dec. 7. That's when China removed many of its anti-Covid measures and appeared to shift, suddenly, from the staunch zero-Covid policy championed by President Xi Jinping to a "live with Covid" stance.

It is not correct to say that Covid cases are exploding in China because all restrictions have been removed. They already were exploding with the zero-Covid rules in place, leading to mass demonstrations across China because the Covid rules were making it almost impossible to work, travel and live a normal life.

China is also recording an official death count of just 5,237 Covid deaths since the disease first reared its head in Wuhan in 2019, a tally that seems increasingly detached from reality day by day but has been championed by Chinese Communist Party officials.

Many businesses in mainland China report disruption due to their own workers contracting Covid and being unable to work. My wife gets custom printing materials and pet tags made in China, but the sourcing companies are contacting her to say production will be delayed because they're short-handed. The companies also say courier deliveries are not functioning as normal due to Covid infections.

Crematorium workers on site in Beijing told Reuters that while the site was busier than normal, they were short-staffed due to their colleagues falling ill.

On Taobao, the Alibaba Group Holding (BABA) online shopping site, one pack of 50 paracetamol-based Panadol pills is on sale for prices as high as ¥2,289 (US$328) inside China. Ordinarily, it would cost around US$19.

Pharmacies in Hong Kong and as far away as Australia and New Zealand have seen a run on cold and flu medicine, with the supply exhausted in some of China's largest cities. Mannings, one of the two leading drug stores in Hong Kong, has no stock of Panadol Cold & Flu Extra available through its online store. Watsons, the other main pharmacy chain in Hong Kong, has completely sold out of all that medicine as well as the "regular" Panadol pills used to treat headaches.

The Lunar New Year will usher in the Year of the Rabbit on Jan. 22, an early date for the holiday. With travel rules significantly eased, this Lunar New Year likely will be the busiest travel season in three years, an event that promises to dramatically enhance the spread of the disease. China last Monday deactivated a contact-tracing app, which had been used nationwide to produce a user code allowing or denying access to travel and public venues.

The city health commission in Guangzhou, the capital of China's most-productive province, Guangdong, today predicted that the virus infections will peak in early January. The justification for the change in official tune on Covid is that the disease has entered a new and less-pathogenic stage. The Guangzhou team reports that 80% of outpatients with fever are young or middle-aged. Nevertheless, the peak of the infection wave will test the limits of China's health system, which is lacking outside large cities, while there's concern about vaccine hesitance among older citizens.

There's already Twitter footage of patients in China receiving intravenous drips while sitting in the cold outside health clinics, and even through their car windows because local clinics are full.

Social media comments have questioned the purpose of the reported Chinese statistics on Covid because they seem to bear no relation to the scale of the disease. Meanwhile, the burgeoning infection count is disrupting a widening circle of companies and industries.

Today, the Japanese chipmaker Renesas Electronics (T:6723 and (RNECY) ) said it had suspended work at its Beijing factory due to Covid-19 infections. Stock and currency traders are reporting that many if not most of their colleagues are absent from trading floors and instead are at home, sick.

Chinese markets have been relatively resilient. But the CSI 300 index of the largest listings in Shanghai and Shenzhen fell 1.5% on Monday on relatively thin volume that may be attributable to low headcounts at brokerages. The Hang Seng Index in Hong Kong fell 0.5%, in line with the narrow declines notched around Asia.

Economists will need to base any predictions of the Chinese economy on private calculations of the extent of Covid inside China. Nomura is forecasting GDP growth of just 2.8% for 2022 in Chin, with "rising downside risks," far from the government's forecast of around 5.5%

Last Thursday and Friday, senior officials held the Central Economic Work Conference, designed to lay out plans for the economy in 2023. There was no forecast for next year's growth, though we can expect Beijing to provide one at its annual March meeting.

Covid was rarely mentioned in the conference statement, and the concept of "common prosperity" used by Xi to push a Maoist and apparently anti-business campaign was dropped entirely. However, we can expect a continued push for deleveraging in the real estate industry because Xi's mantra that "houses are for living in, not for speculation" was repeated.

Also repeated was a new phrase minted at a Politburo meeting a week ago, that monetary policy must be "targeted and forceful." The work conference said it's important for the government to support both private business and state-owned enterprises, but beside the need to balance those two sectors, we know nothing as to what that support entails.

Estimates vary dramatically as to how widespread the Covid infection count and mortality rate in China will be. There's little in the way of natural immunity because zero Covid kept infections very low. And we also know little about the efficacy of Chinese-made vaccines, which have not been extensively tested in peer-reviewed research.

The head of the Center for Disease Control in southwestern Guangxi region, Zhou Jiatong, estimates that China would experience 233 million infections and at least 2 million deaths if it follows the more open Covid response seen in Hong Kong. Should China experience a similar death rate to the United States in its own outbreak, more than 4 million of China's 1.4 billion people would likely die.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, McMillan had no positions in the stocks mentoned.

TAGS: Investing | Politics | Technology | Technology Hardware & Equipment | China | Real Money | Global Equity | Coronavirus

More from Global Equity

Adani Shares Stabilize on Earnings, Early Debt Payment

Alex Frew McMillan
Feb 8, 2023 7:04 AM EST

Flagship Adani Enterprises saw its shares climb 23.1% today, while other group companies generally advanced.

Adani Implosion Threatens Broader Blow to Indian Markets

Alex Frew McMillan
Feb 3, 2023 8:54 AM EST

Indian opposition politicians are demanding an investigation into the government's ties with the Adani Group, as Boris Johnson's brother steps down from linked investment bank.

Alibaba Gaps Lower in U.S. Trading: Here's Why and What's Next

Bruce Kamich
Jan 30, 2023 11:12 AM EST

A stock that rises on shrinking volume is suspect.

Adani Delivers Tome in Response to Short-Sale 'Attack on India'

Alex Frew McMillan
Jan 30, 2023 6:35 AM EST

As the founder slips down the rich list, the Adani Group says Hindenburg Research report is an attack on the very nation of India.

Adani Companies Plunge Under Hindenburg Attack, Hurting Secondary Sale Attempt

Alex Frew McMillan
Jan 27, 2023 9:30 AM EST

Retail investors may baulk now they are being offered Adani Enterprises shares at a range well above their current trading price.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 08:20 AM EST PETER TCHIR

    Powell, 0DTE Options and How I View This Market Right Now

    Fed Chair Powell is saying all the things I think ...
  • 08:22 AM EST REAL MONEY

    LIVE EVENT: Bruce Kamich and Todd Campbell Share Their Stock Market Insights

    This Monday, Feb. 6 at 12 p.m., our very own exper...
  • 02:58 PM EST REAL MONEY

    Sarge Guilfoyle Breaks Down the Jobs Report, Fed Policy and Stocks!

    Watch it here!
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login